SEARCH

SEARCH BY CITATION

  • 1
    Goulmy, E., Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 1997. 157: 125140.
  • 2
    Wallny, H. J. and Rammensee, H. G., Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 1990. 343: 275278.
  • 3
    Simpson, E. and Roopenian, D. C., Minor histocompatibility antigens. Curr. Opin. Immunol. 1997. 9: 655661.
  • 4
    Doolittle, D. P., Davisson, M. T., Guidi, J. N. and Green, M. C., Catalog of mutant genes and polymorphic loci. In Lyon, M. F., Rastan S. and Brown, S. D. M., (Eds.) Genetic variants and strains of the laboratory mouse. Oxford University Press, NJ 1996, pp 17854.
  • 5
    Wang, W., Meadows, L. R., den Haan, J. M. M., Sherman, N. E., Chen, Y., Blokland, E., Shabanowitz, J., Agulnik, A. I., Hendrickson, R. C., Bishop, C. E., Hunt, D. F., Goulmy, E. and Engelhard, V. H., Human H-Y: amale-specific histocompatibility antigen derived from the SMCY protein. Science 1995. 269: 15881590.
  • 6
    Meadows, L. R., Wang, W., den Haan, J. M. M., Blokland, E., Reinhardus, C., Drijfhout, J. W., Shabanowitz, J., Pierce, R., Agulnik, A. I., Bishop, C. E., Hunt, D. F., Goulmy, E. and Engelhard, V. H., The HLA-A*;0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 1997. 6: 273281.
  • 7
    Pierce, R. A., Field, E. D., den Haan, J. M. M., Caldwell, J. A., White, F. M., Marto, J. A., Wang, W., Frost, L. M., Blokland, E., Reinhardus, C., Shabanowitz, J., Hunt, D. F., Goulmy, E. and Engelhard, V. H., Cutting edge: the HLA-A*;0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J. Immunol. 1999. 163: 63606364.
  • 8
    Warren, E. H., Gavin, M. A., Simpson, E., Chandler, P., Page,D. C., Disteche, C., Stankey, K. A., Greenberg, P. D. and Ridell, S. R., The human UTY gene encodes a novel HLA-B8-restricted HY antigen. J. Immunol. 2000. 164: 28072814.
  • 9
    Vogt, M. H., Goulmy, E., Kloosterboer, F. M., Blokland, E., de Paus, R. A., Willemze, R. and Falkenburg, J. H., UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T cell recognition. Blood 2000. 96: 31263132.
  • 10
    Vogt, M. H., de Paus, R. A., Voogt, P. J., Willemze, R. and Falkenburg, J. H., DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 2000. 95: 11001105.
  • 11
    Den Haan, J. M. M., Sherman, N. E., Blokland, E., Huczko, E., Koning, F., Drijfhout, J. W., Skipper, J., Shabanowitz, J., Hunt, D. F., Engelhard, V. H. and Goulmy, E., Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995. 268: 14761480.
  • 12
    Den Haan, J. M. M., Meadows, L. M., Wang, W., Pool, J., Blokland, E., Bishop, T. L., Reinhardus, C., Shabanowitz, J., Offringa, R., Hunt, D. F., Engelhard, V. H. and Goulmy, E., The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 1998. 279: 10541057.
  • 13
    Dolstra, H., Fredrix, H., Maas, F., Coulie, P. G., Brasseur,F., Mensink, E., Adema, G. J., de Witte, T. M., Figdor, C. G. and van de Wiel-van Kemenade, E., A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J. Exp. Med. 1999. 189: 301308.
  • 14
    Brickner, A. G., Warren, E. H., Caldwell, J. A., Akatsuka, Y., Golovina, T. N., Zarling, A. L., Shabanowitz, J., Eisenlohr, L. C., Hunt, D.F., Engelhard, V. H. and Riddell, S. R., The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J. Exp. Med. 2001. 193: 195205.
  • 15
    Pierce, R. A., Field, E. D., Mutis, T., Golovina, T. N., Von Kap-Herr, C., Wilke, M., Pool, J., Shabanowitz, J., Pettenati, M. J., Eisenlohr, L. C., Hunt, D. F., Goulmy, E. and Engelhard, V. H., The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J. Immunol. 2001. 167: 32233230.
  • 16
    Zuberi, A. R., Christianson, G. J., Mendoza, L. M., Shastri, N. and Roopenian, D. C., Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex. Immunity 1998. 9: 687698.
  • 17
    Mendoza, L. M., Paz, P., Zuberi, A., Christianson, G., Roopenian, D. and Shastri, N., Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. Immunity 1997. 7: 461472.
  • 18
    Mendoza, L. M., Villaflor, G., Eden, P., Roopenian, D. and Shastri, N., Distinguishing self from nonself: immunogenicity of the murine H47 locus is determined by a single amino acid substitution in an unusual peptide. J. Immunol. 2001. 166: 44384445.
  • 19
    Ostrov, D. A., Roden, M. M., Shi, W., Palmieri, E., Christianson, G. J., Mendoza, L., Villaflor, G., Tilley, D., Shastri, N., Grey, H., Almo, S. C., Roopenian, D. and Nathenson, S. G., How H13 histocompatibilitypeptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination. J. Immunol. 2002. 168: 283289.
  • 20
    Dolstra, H., Fredrix, H., Preijers, F., Goulmy, E., Figdor, C. G., de Witte, T. M. and van de Wiel-van Kemenade, E., Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. J. Immunol. 1997. 158: 560565.
  • 21
    Martin, P. J., How much benefit can be expected from matching for minor antigens in allogeneic marrow transplantation? Bone Marrow Transplant. 1997. 20: 97100.
  • 22
    Beekman, N. J., van Veelen, P. A., van Hall, T., Neisig, A., Sijts, A., Camps, M., Kloetzel, P. M., Neefjes, J. J., Melief, C. J. and Ossendorp, F., Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. J. Immunol. 2000. 164: 18981905.
  • 23
    Craiu, A., Akopian, T., Goldberg, A. and Rock, K. L., Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl. Acad. Sci. USA 1997. 94: 1085010855.
  • 24
    Kessler, J. H., Beekman, N. J., Bres-Vloemans, S. A., Verdijk, P., van Veelen, P. A., Kloosterman-Joosten, A. M., Vissers, D. C., ten Bosch, G. J., Kester, M. G., Sijts, A., Drijfhout, J. W., Ossendorp, F., Offringa, R. and Melief, C. J., Efficient identification of novel HLA-A*;0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J. Exp. Med. 2001. 193: 7388.
  • 25
    Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, J. H., Vossen, J., Grathwohl, A., Vogelsang, G. B., van Houwelingen, H. C. and van Rood, J. J., Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 1996. 334: 281285.
  • 26
    Tseng, L. H., Lin, M. T., Hansen, J. A., Gooley, T., Pei, J., Smith, A. G., Martin, E. G., Petersdorf, E. W. and Martin, P. J., Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 1999. 94: 29112914.
  • 27
    Akatsuka, Y., Warren, E. H. and Brickner, A. G., Effect of disparity in the newly identified minor histocompatility antigen SKH13 on the development of graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 2000. 96: 202a.
  • 28
    Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E., Liu, J., Shlomchik, M. J. and Emerson, S. G., Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999. 285: 412415.
  • 29
    Mutis, T., Verdijk, R., Schrama, E., Esendam, B., Brand, A. and Goulmy, E., Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999. 93: 23362341.
  • 30
    Fontaine, P., Roy-Proulx, G., Knafo, L., Baron, C., Roy, D. C. and Perrault, C., Adoptive transfer of minor histocompatibility antigen-specific cytotoxic T lymphocytes eradicates leukemia cells without causinggraft-versus-host disease. Nat. Med. 2001. 7: 789794.
  • 31
    Van der Burg, S. H., Ras, E., Drijhout, J. W., Benckhuijsen, W. E., Bremers, A. J., Melief, C. J. and Kast, W. M., An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*;0301. Hum. Immunol. 1995. 44: 189198.
  • 32
    Groettrup, M., Ruppert, T., Kuehn, L., Seeger, M., Standera,S., Koszinowski, U. and Kloetzel, P. M., The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunitsgovern the peptide production by the 20 S proteasome in vitro. J. Biol. Chem. 1995. 270: 2380823815.